This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.20% per year. These returns cover a period from January 1, 1988 through April 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
SenesTech (SNES) Expands in the Netherlands With Q-chem Deal
by Zacks Equity Research
SenesTech's (SNES) collaboration with Q-chem strategically aligns with the Netherlands' Integrated Pest Control program.
Senestech, Inc. (SNES) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
by Zacks Equity Research
Senestech, Inc. (SNES) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
SenesTech's (SNES) New Partnership to Broaden Evolve's Scope
by Zacks Equity Research
The collaboration with a global leader in irrigation solutions for sustainable agriculture aligns with SenesTech's (SNES) target to introduce Evolve to a broader audience.
All You Need to Know About Senestech, Inc. (SNES) Rating Upgrade to Buy
by Zacks Equity Research
Senestech, Inc. (SNES) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
SenesTech (SNES) Likely to Expand Into China With New Deal
by Zacks Equity Research
This partnership provides SenesTech (SNES) with a gateway into one of the largest pest control markets globally, with the support and expertise of Fruit Tree.
Canopy Growth Corporation (CGC) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Canopy Growth Corporation (CGC) delivered earnings and revenue surprises of 60% and 16.19%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Owens & Minor (OMI) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Owens & Minor (OMI) delivered earnings and revenue surprises of 12.50% and 3.56%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
SenesTech (SNES) New Alliance to Aid Expansion in South Africa
by Zacks Equity Research
NSPCA is also working on recommending SenesTech's (SNES) ContraPest to private and state entities and to assist with regulatory issues.
Senestech, Inc. (SNES) Reports Q3 Loss, Misses Revenue Estimates
by Zacks Equity Research
Senestech, Inc. (SNES) delivered earnings and revenue surprises of -4.76% and 40.48%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Senestech, Inc. (SNES) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Senestech, Inc. (SNES) delivered earnings and revenue surprises of -10.53% and 24.52%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Meridian Bioscience (VIVO) Meets Q3 Earnings Estimates
by Zacks Equity Research
Meridian Bioscience (VIVO) delivered earnings and revenue surprises of 0% and 1.45%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Lantheus Holdings (LNTH) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Lantheus Holdings (LNTH) delivered earnings and revenue surprises of 27.14% and 9.68%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Senestech, Inc. (SNES) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Senestech, Inc. (SNES) delivered earnings and revenue surprises of -66.67% and -91.00%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?